Cronos Australia Ltd
ASX:CAU
Intrinsic Value
Cronos Australia Ltd. operates as a medicinal cannabis company. [ Read More ]
The intrinsic value of one
CAU
stock under the Base Case scenario is
0.58
AUD.
Compared to the current market price of 0.36 AUD,
Cronos Australia Ltd
is
Undervalued by 37%.
Cronos Australia Ltd's market capitalization is 200.4m AUD.
CAU stock price is 0.36 AUD.
CAU stock price (0.36 AUD) is 37% less than its Intrinsic Value (0.58 AUD).
CAU has upside potential of 178% compared to the average analyst price target.
Open Wall St Estimates
CAU has positive Net Income for the last twelve months.
CAU has positive Operating Income for the last twelve months.
CAU has positive Free Cash Flow for the last twelve months.
CAU has positive Gross Profit for the last twelve months.
CAU's Revenue has grown by an exceptional 75% over the past 12 months.
CAU has positive three-year average ROE (Return on Equity): 23%. The company is efficient at transforming stockholders' equity into net income.
CAU's ROE (Return on Equity) for the past 12 months is very high and is equal to 45%.
CAU's ROIC (Return on Invested Capital) for the past 12 months is very high and is equal to 79%.
CAU has very high three-year average ROIC (Return on Invested Capital): 38%. The company is very efficient at using invested capital to generate operating income.
CAU's short-term assets (36m AUD) exceed its short-term liabilties (11m AUD).
CAU's D/E (Debt to Equity) is very low and is equal to 0.03.
CAU's long-term assets (47m AUD) exceed its long-term liabilties (12m AUD).
CAU has negative Net Debt. This means that the company has more cash and short-term investments (19m AUD) than debt (1m AUD).
CAU's Altman Z-Score is very high and is equal to 14.5.
CAU doesn't generate enough operating income (20m AUD) to safely cover interest payments on its debt (-210k AUD).
Valuation Backtest
Cronos Australia Ltd
Run backtest to discover the historical profit from buying and selling
CAU
stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Cronos Australia Ltd
Balance Sheet Decomposition
Cronos Australia Ltd
| Current Assets | 36m |
| Cash & Short-Term Investments | 18.8m |
| Receivables | 9.3m |
| Other Current Assets | 7.8m |
| Non-Current Assets | 10.9m |
| PP&E | 2.4m |
| Intangibles | 7.1m |
| Other Non-Current Assets | 1.4m |
| Current Liabilities | 10.9m |
| Accounts Payable | 9.8m |
| Other Current Liabilities | 1m |
| Non-Current Liabilities | 1m |
| Long-Term Debt | 1m |
| Other Non-Current Liabilities | 6.3k |
Earnings Waterfall
Cronos Australia Ltd
|
Revenue
|
117.3m
AUD
|
|
Cost of Revenue
|
-76.8m
AUD
|
|
Gross Profit
|
40.5m
AUD
|
|
Operating Expenses
|
-20.3m
AUD
|
|
Operating Income
|
20.3m
AUD
|
|
Other Expenses
|
-6.5m
AUD
|
|
Net Income
|
13.8m
AUD
|
Free Cash Flow Analysis
Cronos Australia Ltd
CAU Profitability Score
Profitability Due Diligence
Cronos Australia Ltd's profitability score is 68/100. The higher the profitability score, the more profitable the company is.
Score
Cronos Australia Ltd's profitability score is 68/100. The higher the profitability score, the more profitable the company is.
CAU Solvency Score
Solvency Due Diligence
Cronos Australia Ltd's solvency score is 74/100. The higher the solvency score, the more solvent the company is.
Score
Cronos Australia Ltd's solvency score is 74/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
CAU Price Targets Summary
Cronos Australia Ltd
According to Wall Street analysts, the average 1-year price target for
CAU
is 1 AUD
.
Shareholder Return
CAU Price
Cronos Australia Ltd
| Average Annual Return | 1.79% |
| Standard Deviation of Annual Returns | 71.22% |
| Max Drawdown | -81% |
| Market Capitalization | 200.4m AUD |
| Shares Outstanding | 554 814 000 |
| Percentage of Shares Shorted |
N/A
|
Company Profile
Cronos Australia Ltd
Country
Industry
Market Cap
Dividend Yield
Description
Cronos Australia Ltd. operates as a medicinal cannabis company. The company is headquartered in Melbourne, Victoria. The company went IPO on 2019-11-07. The firm is engaged in developing and distributing of medical and consumer cannabinoid products and services. The firm distributes the Adaya and PEACE NATURALS range of medicinal cannabis products in Australia through medical practitioner. The company owns Cannadoc Health Pty Ltd, a medicinal cannabis clinic business and owns CDA Health Pty Ltd, distributor of medicinal cannabis products via its BHC’s Canview platform and provider of medicinal cannabis clinic services via its CDA clinics.
Contact
IPO
Employees
Officers
The intrinsic value of one
CAU
stock under the Base Case scenario is
0.58
AUD.
Compared to the current market price of 0.36 AUD,
Cronos Australia Ltd
is
Undervalued by 37%.
You don't have any saved screeners yet
